Internal Medicine, Endocrinology, Diabetes, & Metabolism · Plymouth, MA
NPI
1780750455
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
0
Medicare group memberships
Hospitals
4
Hospital affiliations
45 Resnik Rd, Suite 303
Plymouth, MA, 02360
Phone (508) 746-7858
Medicare paid, 2024
$89K
1,353 services
Medicare patients, 2024
438
Average age 75
Drug cost, 2024
$1.5M
6,280 prescriptions
Company payments, 2025
$252
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Christopher Coakley was code 99213 (office e&m - established), 476 times for 288 patients. In total Christopher Coakley billed 1,353 services in 25 codes, and Medicare paid $89K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-03-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 476 | 288 | $68.49 | $33K |
| 99232 Hospital E&M - Subsequent | Facility | 227 | 45 | $61.94 | $14K |
| 95251 Test - Miscellaneous | Office | 88 | 54 | $27.14 | $2,389 |
| 99223 Hospital E&M - Initial | Facility | 81 | 73 | $136.12 | $11K |
| 99497 Care Management/Coordination | Office | 54 | 54 | $52.10 | $2,813 |
| G0442 Annual alcohol misuse screening, 5 to 15 minutes | Office | 48 | 48 | $19.30 | $926 |
| G0447 Face-to-face behavioral counseling for obesity, 15 minutes | Office | 47 | 32 | $25.29 | $1,189 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 47 | 47 | $130.81 | $6,148 |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 45 | 45 | $19.29 | $868 |
| 99204 Office E&M - New | Office | 42 | 42 | $124.29 | $5,220 |
| 99214 Office E&M - Established | Office | 39 | 35 | $92.53 | $3,609 |
| G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 37 | 26 | $43.25 | $1,600 |
| 93000 Electrocardiogram | Office | 14 | 14 | $9.90 | $139 |
| 99495 Chronic, Principal, and Transitional Care Management | Office | 12 | 12 | $167.06 | $2,005 |
By year: 2022 $88K for 1,204 services; 2023 $86K for 1,244 services; 2024 $89K for 1,353 services.
Medicare prescription drug claims, 2024
In 2024, the drug Christopher Coakley prescribed most often to Medicare patients was Metformin Hcl, with 279 prescriptions and refills. In total Christopher Coakley wrote 6,280 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Metformin Hcl Generic | 279 | 727 | 71 | $2,546 |
| Atorvastatin Calcium Generic | 277 | 749 | 74 | $3,559 |
| Levothyroxine Sodium Generic | 271 | 638 | 64 | $1,974 |
| Ozempic Semaglutide | 179 | 211 | 28 | $189K |
| Lisinopril Generic | 164 | 455 | 45 | $1,028 |
| Rosuvastatin Calcium Generic | 156 | 447 | 43 | $6,323 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 129 | 291 | 38 | $27K |
| Alprazolam Generic | 109 | 119 | 12 | $1,107 |
| Gabapentin Generic | 108 | 153 | 23 | $1,278 |
| Glimepiride Generic | 104 | 267 | 29 | $979 |
| Testosterone Generic | 100 | 105 | 16 | $11K |
| Januvia Sitagliptin Phosphate | 97 | 208 | 26 | $112K |
| Losartan Potassium Generic | 95 | 243 | 25 | $1,385 |
| Mounjaro Tirzepatide | 91 | 117 | 23 | $123K |
| Trulicity Dulaglutide | 90 | 101 | 18 | $98K |
Brand drugs: 1,790 claims; generic drugs: 4,151 claims; opioid claims: 270.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Christopher Coakley $252 ($252 in general payments such as food, travel and fees) from 3 companies. The largest payer was Novo Nordisk Inc with $114.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.